CD19-Targeted Normal and CLL Patient T Cells Expanded with Beads Can Eradicate Systemic Tumors In Vivo

被引：2

作者：

Stefanski, J. ^{[1
]}

Brentjens, R. ^{[2
]}

Hollyman, D. ^{[1
]}

Bonyhadi, M.

Sadelain, M. ^{[1
,3
]}

Riviere, I. ^{[1
,3
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Gene Transfer & Somat Cell Engn Lab, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10021 USA

来源：

MOLECULAR THERAPY | 2006年 / 13卷

关键词：

D O I：

10.1016/j.ymthe.2006.08.322

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

268

引用

页码：S102 / S102

页数：1

共 50 条

[1] Unexpected Toxicity of Cyclophosphamide Followed by Adoptively Transferred CD19-Targeted T Cells in a Patient with Bulky CLL
Brentjens, Renier J.
Riviere, Isabelle
Hollyman, Daniel
Taylor, Clare
Nikhamin, Yan
Stefanski, Jolanta
Lee, James
Yeh, Raymond
Santos, Elmer
Sadelain, Michel
MOLECULAR THERAPY, 2009, 17 : S157 - S157
[2] Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
Bergmann, Christina
Mueller, Fabian
Distler, Joerg H. W.
Gyoerfi, Andrea-Hermina
Voelkl, Simon
Aigner, Michael
Kretschmann, Sascha
Reimann, Hannah
Harrer, Thomas
Bayerl, Nadine
Boeltz, Sebastian
Wirsching, Andreas
Taubmann, Jule
Roesler, Wolf
Spriewald, Bernd
Wacker, Jochen
Atzinger, Armin
Uder, Michael
Kuwert, Torsten
Mackensen, Andreas
Schett, Georg
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (08) : 1117 - 1120
[3] CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
Mougiakakos, Dimitrios
Kroenke, Gerhard
Voelkl, Simon
Kretschmann, Sascha
Aigner, Michael
Kharboutli, Soraya
Boeltz, Sebastian
Manger, Bernhard
Mackensen, Andreas
Schett, Georg
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (06): : 567 - 569
[4] Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure
Gauthier, Jordan
Hirayama, Alexandre V.
Purushe, Janaki
Hay, Kevin A.
Lymp, James
Li, Daniel H.
Yeung, Cecilia C. S.
Sheih, Alyssa
Pender, Barbara S.
Hawkins, Reed M.
Vakil, Aesha
Tinh-Doan Phi
Steinmetz, Rachel N.
Shadman, Mazyar
Riddell, Stanley R.
Maloney, David G.
Turtle, Cameron J.
BLOOD, 2020, 135 (19) : 1650 - 1660
[5] Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL
Geyer, Mark B.
Riviere, Isabelle
Senechal, Brigitte
Wang, Xiuyan
Wang, Yongzeng
Purdon, Terence J.
Hsu, Meier
Devlin, Sean M.
Palomba, M. Lia
Halton, Elizabeth
Bernal, Yvette
van Leeuwen, Dayenne G.
Sadelain, Michel
Park, Jae H.
Brentjens, Renier J.
JCI INSIGHT, 2019, 4 (09)
[6] Generation of CD19-Targeted Chimeric Antigen Receptor T Cells
Kiani, Jafar
Naderi, Mahmood
Torabi-Rahvar, Monireh
Ranjbar, Azam
Aghayan, Hamid-Reza
Janzamin, Ehsan
Ahmadbeigi, Naser
ARCHIVES OF IRANIAN MEDICINE, 2019, 22 (01) : 7 - 10
[7] CD19-targeted CAR T cells in refractory antisynthetase syndrome
Mueller, Fabian
Boeltz, Sebastian
Knitza, Johannes
Aigner, Michael
Voelkl, Simon
Kharboutli, Soraya
Reimann, Hannah
Taubmann, Jule
Kretschmann, Sascha
Roesler, Wolf
Manger, Bernhard
Wacker, Jochen
Mougiakakos, Dimitrios
Jabari, Samir
Schroeder, Rolf
Uder, Michael
Roemer, Frank
Kroenke, Gerhard
Mackensen, Andreas
Schett, Georg
LANCET, 2023, 401 (10379): : 815 - 818
[8] CD19-Targeted T Cells for Hematologic Malignancies Clinical Experience to Date
Davila, Marco L.
Sauter, Craig
Brentjens, Renier
CANCER JOURNAL, 2015, 21 (06): : 470 - 474
[9] Donor-derived CD19-targeted T cells in allogeneic transplants
Magnani, Chiara Francesca
Biondi, Andrea
Biagi, Ettore
CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 497 - 502
[10] IN VIVO EXPANSION OF GAMMA DELTA T CELLS BY A CD19-TARGETED BUTYROPHILIN HETERODIMER LEADS TO ELIMINATION OF PERIPHERAL B CELLS
De Silva, Suresh
Fromm, George
Gonzalez, Louis
Patel, Arpita
Yoon, Kyung
Opheim, Zachery
Farmer, Robert
Chamberlain, Dean
Schreiber, Taylor
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A413 - A413

← 1 2 3 4 5 →